Lansdall CJ, McDougall F, Butler LM, Delmar P, Pross N, Qin S, McLeod L, Zhou X, Kerchner GA, Doody RS. Establishing clinically meaningful change on outcome assessments frequently used in trials of mild cognitive impairment due to Alzheimer's disease. J Prev Alzheimers Dis. 2023;10(1):9-18. doi: 10.14283/jpad.2022.102
Romano (DeMuro) C, Novak G, Choi J, Qin S, Henley D, Donohue M, Romano G, Raman R, Amariglio R, Aisen P, Sperling R. Assessing clinically meaningful functional outcomes in preclinical alzheimer's disease. Poster presented at the 15th Conference Clinical Trials Alzheimer's Disease 2022; November 29, 2022. San Francisco, CA. [abstract] J Prev Alzheimers Dis. 2022 Dec 3; 9(Supplement 1):S186-7.
Nagar SP, Patel A, Bali V, Aparasu RR. Prevalence and predictors of pediatric depression in the United States. Int J Pharm Sci Nanotech. 2014 Sep;7(3):91-7.
Nagar SP, Mhatre S, Hatfeild MD, Aparasu RR. Patterns and predictors of antipsychotic usage among U.S. adults: a national co-morbidity survey replication study. Int J Pharm Sci Nanotech. 2014 Apr;7(2):52-68.
Yang J, Bogerd HP, Wang PJ, Page DC, Cullen BR. Two closely related human nuclear export factors utilize entirely distinct export pathways. Mol Cell. 2001 Aug;8(2):397-406.